ライフサイエンスコーパス: esophagogastroduodenoscopy

1 derwent 48-hour esophageal pH monitoring and esophagogastroduodenoscopy.

2 in cirrhosis patients to prevent unnecessary esophagogastroduodenoscopy.

3 ered a dyspepsia questionnaire and underwent esophagogastroduodenoscopy.

4 en underwent either serologic testing and/or esophagogastroduodenoscopy.

5 logic findings and 11 had normal findings at esophagogastroduodenoscopy.

6 taken and underwent colonoscopy, followed by esophagogastroduodenoscopy.

7 e 10 patients, esophagitis was documented by esophagogastroduodenoscopy.

8 Gut T(H)2 cells were obtained by means of esophagogastroduodenoscopy.

9 Patients were evaluated by esophagogastroduodenoscopy, 24-hour esophageal pH studie

10 tive evaluation included symptom assessment, esophagogastroduodenoscopy, 24-hour pH evaluation, and e

11 efinition) on PPIs underwent barium swallow, esophagogastroduodenoscopy, 48-hour esophageal pH monito

12 ve unexplained nausea but normal findings on esophagogastroduodenoscopy, a gastric-emptying test, and

13 ntestinal bleeding, and negative findings on esophagogastroduodenoscopy and colonoscopy, CE should be

14 o have CD-associated antibodies were offered esophagogastroduodenoscopy and duodenal biopsy analysis.

15 ong eligible patients scheduled for elective esophagogastroduodenoscopy and patients eligible for scr

16 We enrolled patients scheduled for esophagogastroduodenoscopy and positive for H. pylori in

17 pants then were selected randomly to undergo esophagogastroduodenoscopy and were given the Abdominal

18 2,091,590 veterans who underwent outpatient esophagogastroduodenoscopy and/or colonoscopy during fis

19 e study of veterans who underwent outpatient esophagogastroduodenoscopy and/or colonoscopy from fisca

20 ients were also assessed by FibroScan, HVPG, esophagogastroduodenoscopy, and liver biopsy.

21 ardia and duodenal bulb was performed during esophagogastroduodenoscopy, but histologic findings at h

22 underwent a diagnostic workup that included esophagogastroduodenoscopy, colonoscopy, and barium radi

23 Esophagogastroduodenoscopy, colonoscopy, and pathology r

24 rminate source and had negative results from esophagogastroduodenoscopy, colonoscopy, small-bowel exa

25 in tissue biopsy from endoscopy in 1 from 10 esophagogastroduodenoscopies (EGD), 0 from 7 colonoscopi

26 it has been suggested that VCE could replace esophagogastroduodenoscopy (EGD) and biopsy under certai

27 nt portions of the cost and complications of esophagogastroduodenoscopy (EGD) are related to sedation

28 namics, time from bleeding, comorbidity, and esophagogastroduodenoscopy (EGD) findings to predict ris

29 ere obtained from patients with dyspepsia on esophagogastroduodenoscopy (EGD) for rapid urease test,

30 ted tomography (CT) in 40 of 53 patients, on esophagogastroduodenoscopy (EGD) in 11 of 36 patients, a

31 Current guidelines recommend esophagogastroduodenoscopy (EGD) in patients with cirrho

32 y, and to determine the role of preresection esophagogastroduodenoscopy (EGD) in predicting the patie

33 Esophagogastroduodenoscopy (EGD) is done often for vario

34 practice sites in 21 states provided 18,444 esophagogastroduodenoscopy (EGD) reports, 20,748 colonos

35 Unsedated esophagogastroduodenoscopy (EGD) using conventional 8-11

36 After PV isolation, esophagogastroduodenoscopy (EGD) was performed to assess

37 98 of 575 (51.8%) patients who had undergone esophagogastroduodenoscopy (EGD), colonoscopy or both fo

38 ncluding clinical evaluation, and results of esophagogastroduodenoscopy (EGD), manometry, and pH moni

39 oup 1 were found to have NDBE at their first esophagogastroduodenoscopy (EGD).

40 t of the study, 50 adults with EoE underwent esophagogastroduodenoscopies (EGDs), biopsies, and skin-

41 by a urea breath test and were subjected to esophagogastroduodenoscopy, followed by histology, cultu

42 Varices were documented by esophagogastroduodenoscopy in 287 (72.5%) of 396 analyze

43 sophagus cases by age, race, and gender with esophagogastroduodenoscopy negative for Barrett's esopha

44 ients required mask ventilation during their esophagogastroduodenoscopy or colonoscopy, respectively

45 Median time from first esophagogastroduodenoscopy to stage 4 disease was 22.4 y

46 Esophagogastroduodenoscopy was performed after 4 wk to a

47 Esophagogastroduodenoscopy was performed because of a su

48 Esophagogastroduodenoscopy was performed before and afte

49 372 consecutive patients undergoing esophagogastroduodenoscopy were carefully searched for t

50 Barium swallows and esophagogastroduodenoscopy were performed in all patient

51 ported outcome instrument and then underwent esophagogastroduodenoscopy with esophageal biopsy collec

52 h HVPG below 12 mmHg and prevent unnecessary esophagogastroduodenoscopy with its associated morbidity

53 ional study in adult EoE patients undergoing esophagogastroduodenoscopy with propofol sedation was co

54 ss-sectional study of patients who underwent esophagogastroduodenoscopy with submission of gastric an